Grace Therapeutics (GRCE) PT Lowered to $4 at Craig-Hallum Apr 24, 2026 11:21AM
Grace Therapeutics (GRCE) PT Lowered to $8 at TD Cowen Apr 23, 2026 04:26PM
FDA issues complete response letter for Grace Therapeutics' GTx-104 drug Apr 23, 2026 01:13PM
Grace Therapeutics raises $4 million through warrant exercises Oct 23, 2025 08:02AM
Grace Therapeutics receives sixth US patent for GTx-104 dosing regimen Sep 18, 2025 08:31AM


Jun 25, 2025 08:03AM Grace Therapeutics (GRCE) Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
May 2, 2025 05:29AM TD Cowen Starts Grace Therapeutics (GRCE) at Buy
Apr 9, 2025 08:04AM Grace Therapeutics (GRCE) Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
Feb 18, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Grace Therapeutics (GRCE)
Feb 10, 2025 08:05AM Grace Therapeutics (GRCE) Announces $30M Private Placement
Feb 10, 2025 08:04AM Grace Therapeutics (GRCE) Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104
Oct 25, 2024 08:01AM Acasti Pharma (ACST) Announces Corporate Name Change to Grace Therapeutics (GRCE)